An Introduction to Psychedelics and Women’s Health

Lately more and more investors are turning their attention, and more importantly their capital, to the psychedelics industry. Overall there are three reasons for this trend: A ´Global need for effective mental health treatments, evolving legislation and regulation, and somewhat broad support in the public.

In this session we will discuss the psychedelics space with a special focus on women’s health and are joined by Pamela Hadfield, the Co-founder of Eastra Health, the world’s first female-focused biotech company dedicated to developing psychedelic-derived medicines specifically for women.

You’ve found some of our exclusive Inner Circle Content.

This article is only available for our Inner Circle Members. To read on: